Search

Your search keyword '"Watson, David J. G."' showing total 21 results

Search Constraints

Start Over You searched for: Author "Watson, David J. G." Remove constraint Author: "Watson, David J. G."
21 results on '"Watson, David J. G."'

Search Results

1. A consensus protocol for functional connectivity analysis in the rat brain

2. Dopaminergic neuromodulation of prefrontal cortex activity requires the NMDA receptor coagonist D-serine

3. Author Correction: A consensus protocol for functional connectivity analysis in the rat brain

4. Dopaminergic neuromodulation of prefrontal cortex activity requires the NMDA receptor coagonist D-serine

6. The impact of anxiety on chronic musculoskeletal pain and the role of astrocyte activation

8. 5‐HT 6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia

9. S32212, a Novel Serotonin Type 2C Receptor Inverse Agonist/α2-Adrenoceptor Antagonist and Potential Antidepressant: II. A Behavioral, Neurochemical, and Electrophysiological Characterization

12. 5-HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia.

13. Blockade of dopamine D3 but not D2 receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment.

14. The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures.

15. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.

16. Anxiety enhances pain in a model of osteoarthritis and is associated with altered endogenous opioid function and reduced opioid analgesia.

17. Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management.

18. The impact of anxiety on chronic musculoskeletal pain and the role of astrocyte activation.

19. The dopamine D₃-preferring D₂/D₃ dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia.

20. Blockade of dopamine D₃ but not D₂ receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment.

21. Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: a key role for the prefrontal cortex.

Catalog

Books, media, physical & digital resources